Intermittent therapy with rifampin once a week in advanced pulmonary tuberculosis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D011859:Radiography; D012293:Rifampin / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D000637:Transaminases / Q000097:blood; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology
D001798:Blood Proteins; D004977:Ethambutol; D000637:Transaminases; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin